Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Thanks for spotting that. Who'd have thought that the old BAX deal would come back to life with Shire. Even more importantly, the comments from management indicate a strong belief in the value of the Enhanze Technology, which was the reason some of us invested in HALO all those years ago.

Question: The comments quoted seem to imply that the BAX deal included rights to other targets beyond Gammagard. It's been so long that I can't remember if that is true. If Shire wants to proceed with developing other targets for subcu, is it rather the case that they would need to buy additional rights from HALO?

Good luck!
-Fritz